On behalf of Kaiser Gornick LLP posted in Dangerous Pharmaceuticals on Friday, December 14, 2012 Bevacizumab injections prepared by a Florida compounding pharmacy blinded almost a dozen patients according to news reports. The patients were given bevacizumab, also known as [...]
Massachusetts Board of Pharmacy director James Coffey was recently fired after a failing to provide enough pharmacy oversight before the deadly fungal meningitis outbreak that has sickened hundreds and killed around 30. Officials say that Coffey failed to disclose a [...]
A recent editorial in the British Medical Journal calls on pharmaceutical companies to make all of their clinical trial data available to public scrutiny. Although drugmakers have saved countless lives with their innovations and breakthroughs, many companies continue to hide [...]
A study recently published by USA Today reveals that compounding pharmacies are rarely held accountable for producing dangerous pharmaceuticals such as the NECC back injections that caused a nationwide fungal meningitis outbreak. Reporters looked at legal action taken by regulatory [...]
Asbestos is a naturally-occurring mineral that was mined for over a century for use in thousands of products. The use of asbestos products was severely restricted in the late 1970s because it became well-known that asbestos causes a variety of [...]
A recent article from Forbes Magazine highlights the extreme gaps in the U.S. Food and Drug Administration's approval process for potentially dangerous pharmaceutical drugs. The FDA is notorious for failing to thoroughly scrutinize the claims that pharmaceutical companies make regarding [...]
Drugmaker Hospira Inc. has recalled some of its IV solution products due to a report of mold contamination which may endanger patients. The U.S. Food and Drug Administration announced that the recall impacts Lactated Ringer's and 5% Dextrose Injection, USP, [...]
The FDA recently warned of a recall affecting TorFlex Transseptal Guiding Sheath Kit manufactured between December 2011 and July 2013. The maker of this defective medical device, Baylis Medical Company Inc., recalled the device and issued an Urgent Device Recall [...]
The investigation into a deadly meningitis outbreak continues after a defective pharmaceutical killed over two dozen patients and sickened over 386. Authorities say that a fungus-contaminated steroid was shipped clinics in at least 23 states from a specialty pharmacy in [...]
The FDA recently warned that its lab analysis has identified an undeclared ingredient in multiple dietary supplements marketed as natural remedies for weight loss. The ingredient in question - sibutramine - "was removed from the U.S. market in October 2010 [...]
A recent article in the New York Times indicates that popular diabetes drugs such as Avandia and Actos have been linked to blindness in some patients. The article highlights the dangers of thiazolidinediones, a group of diabetes medications that have [...]
We have covered many vaginal mesh implant cases in previous posts. Although medical device manufacturer Johnson & Johnson agreed to stop selling these defective medical devices this summer, more evidence indicates that the company was aware that these products should [...]
In our last post, we discussed the wave of litigation brought against medical device company Johnson & Johnson over its defective transvaginal mesh implants. Hundreds of lawsuits have been filed against J&J and other mesh implant manufacturers by women who [...]
California product liability claims typically fall under one of three legal theories: design defects, manufacturing defects and failure-to-warn of known hazards. CNN reports that manufacturers of surgical clips may face failure-to-warn product liability litigation from kidney donors who suffered serious [...]
In our last post, we discussed a $3 billion settlement agreed to by drugmaker GlaxoSmithKline to settle allegations that it illegally marketed dangerous pharmaceuticals for unapproved, off-label uses. In addition to the antidepressant Paxil, authorities allege that the drugmaker mismarketed [...]
British pharmaceutical giant GlaxoSmithKline (GSK) recently agreed to pay a record-breaking $3 billion settlement for the improper marketing of many dangerous pharmaceuticals, including Paxil. Federal regulators say that the drugmaker marketed several of its drugs for unapproved, off-label uses. This [...]
In our last post, we discussed a recent pharmaceutical liability lawsuit filed against drugmaker Pfizer Inc. and its California distributor. Several users of Pfizer's smoking cessation drug Chantix allege that Pfizer failed to warn them that the drug could cause [...]
Pfizer Inc. and its California distributor, McKesson Corp., were recently sued in Los Angeles Superior Court by dozens of individuals who suffered adverse side effects after taking the drug varenicline, also known as Chantix. Chantix is designed to mimic the [...]
Researchers say that the Food and Drug Administration's system of recall notifications is inadequate and may expose patients to defective pharmaceuticals long after a recall is issued. ABC News reported on a study covering FDA notifications for the most serious [...]
German drugmaker Bayer AG is set to pay more than $100 million to settle hundreds of lawsuits brought by women alleging that its Yasmin birth control pills cause dangerous blood clots. Several Yasmin-related blood clots have caused fatal strokes and [...]
Medical device giant Johnson & Johnson recently told a federal judge that it plans to stop sales of four of itstransvaginal mesh implants. The announcement by J&J's Ethicon unit comes at a time when the company faces hundreds of lawsuits [...]
The Food and Drug Administration recently approved the first prescription diet drug in a decade. The drug, Belviq, is made by Arena Pharmaceuticals, which claims that it can help obese dieters lose weight by modifying their brain chemistry to create [...]
Boston Scientific recently revealed that a medical device defect in its implantable cardiac defibrillators has killed at least one person. The defect is present in the company's Cognis and Teligen defibrillators which have already been implanted in over 233,000 patients [...]
The wave of transvaginal mesh lawsuits have spilled across the border to Canada. Medical device giant Johnson & Johnson faces a newly minted class action in Canada in addition to the massive wave of transvaginal mesh cases in California and [...]
The father of a 24-year-old patient recently filed a product liability lawsuit against Intuitive Surgical, Inc. alleging that the company's da Vinci surgical robot led to his daughter's death. The patient died two weeks after her hysterectomy surgery and her [...]
This week, we have discussed a mesothelioma case involving a California oil refinery worker's family. The worker died after developing mesothelioma and his family filed a product liability lawsuit against the manufacturer of the asbestos-containing insulation that likely caused the [...]
In our last post, we discussed a wrongful death and product liability lawsuit brought by the family of a California oil refinery worker who died of mesothelioma. The family brought the lawsuit against the manufacturer of asbestos insulation that the [...]
The family of a former California oil refinery worker recently brought a wrongful death and product liability lawsuit against the manufacturer of asbestos insulation. Many individuals throughout California have been exposed to asbestos-containing materials in the workplace. Asbestos is a [...]
It is not uncommon for large drugmakers to market drugs for uses that have not been approved by the U.S. Food and Drug Administration. This practice, known as "off-label marketing," can result in billions of dollars in profits for drugmakers, [...]
The giant drugmaker Takeda Pharmaceutical Co. has failed to secure federal approval to market its follow-up to the diabetes drug Actos. Takeda sought to sell its diabetes drug, called alogliptin, in the U.S., but the Food and Drug Administration has [...]
Pharmaceutical giant Johnson & Johnson may have to pay upwards of $1.8 billion to settle a serious lawsuit with the Justice Department and several states arising out of the marketing of the antipsychotic Risperdal. Authorities say the company marketed Risperdal [...]
A recently unsealed whistleblower complaint alleges that the U.S. arm of Japanese drugmaker Takeda Pharmaceutical Co. hid the adverse effects of its blockbuster diabetes drug Actos. The lawsuit alleges that Takeda Pharmaceuticals North America Inc. intentionally hid the fact that [...]
A recent investigation by Consumer Reports indicates that transvaginal mesh was not tested before it was released to the market. Transvaginal mesh is just one of many defective medical devices that the Food and Drug Administration (FDA) allowed onto the [...]
Drugmaker Takeda Pharmaceutical Co. Ltd. recently reached a deal to buy Philadelphia-based URL Pharma Inc., a maker of gout treatment medication, for $800 million. The deal is expected to close within the next two months. Takeda is the Japanese drugmaker [...]
A new investigative study by the British Medical Journal (BMJ) shows a potential for significant danger with all or most metal-on-metal hip implants. In addition to higher than average failure rates, the metal-on-metal implants can leach metal ions into the [...]
Every year, thousands of women experience pelvic organ prolapse - a condition in which organs in the abdomen prolapse (bulge) into the vaginal area. Generally, doctors treat this condition by surgically implanting mesh between the abdomen and the vaginal area [...]
For those with arthritis and other diseases of the joints, replacement surgeries can improve quality of life and mobility. In 2007, almost 800,000 knee and hip replacements were performed. It is estimated that more than 750,000 Americans have replacement surgery [...]
